TrialJournal of lipid research2009
Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
Bruno Vergès et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
TrialJournal of lipid research2009
Bruno Vergès et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.